Estrogen receptors are members of the steroid hormone superfamily of nuclear receptors that act as ligandactivated transcription factors. Similar to other steroid hormone receptors, estrogen receptor a (ERa) is a substrate for protein kinases, and phosphorylation has profound effects on the function of this receptor. In this study, we show that ERa associates with c-Abl nonreceptor tyrosine kinase. The direct interaction is mediated by two PXXP motifs of ERa and the c-Abl SH3 domain. Mutational analysis and in vitro kinase assays show that ERa can be phosphorylated on two sites, tyrosine 52 (Y-52) and tyrosine 219 (Y-219). ERa phosphorylation by c-Abl stabilizes ERa, resulting in enhanced ERa transcriptional activity and increased expression of endogenous ERa target genes. Furthermore, ERa phosphorylation at the Y-219 site affects DNA binding and dimerization by ERa. Both the c-Abl inhibitor and the c-Abl kinase dead mutation abolish the c-Ablinduced accumulation of ERa and enhancement of ERa transcriptional activity, indicating that c-Abl kinase activity is required for regulation of the ERa function. Moreover, the ERa (Y52,219F) mutant shows reduced breast cancer cell growth and invasion. Taken together, these results show that c-Abl is a novel kinase that upregulates ERa expression and promotes breast cancer cell proliferation, suggesting a great potential for this kinase to function as a therapeutic target for breast cancer.
Introduction
Estrogen receptors (ERa and ERb) are members of the steroid hormone superfamily of nuclear receptors that act as ligand-activated transcription factors. Both the receptors regulate gene transcription either by binding directly to estrogen-responsive elements (ERE) located within the promoter regions of target genes or by interacting with other transcription factors (Katzenellenbogen et al., 2000; Klinge, 2000; Aranda and Pascual, 2001) . Activation of ERa is important for many biological processes, including cell growth and differentiation, morphogenesis and programmed cell death. In addition, ERa has an important function in the development and progression of breast cancer by regulating genes and signaling pathways involved in cellular proliferation (Katzenellenbogen, 1996; Katzenellenbogen et al., 1997; Frech et al., 2005; Acconcia et al., 2006) . Regulation of gene expression by ERa requires the coordinate activity of ligand binding, phosphorylation and cofactor interactions. Phosphorylations of ERa on serines 104, 106, 118 and 167, and tyrosine 537, have been shown by using deletional or point mutation analyses or by high-pressure liquid chromatography purification (Arnold et al., 1994; Le Goff et al., 1994; Castano et al., 1997; Deborah, 2003; Acconcia et al., 2006; Rayala et al., 2006) . Mutation of serine 118 to alanine reduces ERa transcriptional activity (Joel et al., 1995) , whereas mutation of tyrosine 537 leads to increased ligand-independent ERa transcriptional activation by affecting its DNA-binding ability and dimerization (Arnold et al., 1995 (Arnold et al., , 1997 . Phosphorylation of ERa at serine 118 is mediated by the RAS/MAPK pathway (Joel et al., 1995 (Joel et al., , 1998 Kato et al., 1995; Bunone et al., 1996) , whereas phosphorylation of ERa at tyrosine 537 is mediated by members of the Src family of tyrosine kinases in vitro (Migliaccio et al., 2000) . Phosphorylation of ERa by casein kinase II and pp90rsk1 on serine 167 in vitro has also been shown (Kato et al., 1995; Chen et al., 1999; Clark et al., 2001; Hiroko et al., 2005; Senad et al., 2005) . However, the intracellular signaling pathways modulating ERa transcriptional activity through phosphorylation are not fully understood.
c-Abl is a Src-like nonreceptor protein kinase (PTK) that is ubiquitously expressed. c-Abl PTK is localized both in the nucleus and in the cytoplasm, and its kinase activity is tightly regulated through different mechanisms (Nagar et al., 2003; Pendergast, 2002; Plattner et al., 1999) . Studies suggest that c-Abl and its homolog Arg have important functions in regulating cell proliferation, apoptosis, adhesion, cell migration and stress responses (Yuan et al., 1996 (Yuan et al., , 1999 Baskaran et al., 1997; Agami et al., 1999; Brasher and Van Etten, 2000; Raina et al., 2006; Srinivasan et al., 2008) . The existence of Cterminal DNA-binding motifs and nuclear localization signals in c-Abl enables shuttling between cytoplasmic and nuclear compartments, extending the exposure to additional Abl kinase substrates (Wen et al., 1996; Taagepera et al., 1998; Yoshida et al., 2005) . The activated forms of Abl kinases (BCR-Abl, Tel-Abl and Tel-Arg) induce the development of human leukemia (Skorski et al., 1998; Druker et al., 2001; Pendergast, 2001; Kim et al., 2004) . Recent studies suggest that Abl kinases are constitutively activated in breast cancer cells and constitutive activation of Abl kinases promotes breast cancer cell invasion (Srinivasan and Plattner, 2006; Jallal et al., 2007; Srinivasan et al., 2008) . Although the mechanism by which BCR-Abl drives leukemiagenesis is well understood, little is known regarding how Abl promotes progression of solid tumors.
In this study, we show for the first time that ERa is upregulated by c-Abl through a mode of phosphorylation-induced interaction, resulting in ERa stabilization, increased transcriptional activity and increased expression of endogenous ERa target genes. We further show that c-Abl kinase is involved in breast cancer cell growth and invasion through regulation of ERa signaling, identifying a novel mechanism by which Abl kinases are constitutively activated in breast cancer cells.
Results
ERa associates with c-Abl in vivo and in vitro Amino-acid sequence analysis revealed that ERa contains two putative PXXP motifs, one (PYGP, aa 79-82) located in the AF1 domain and the other (PTRP, aa 333-336) in the AF2 domain (Supplementary Figure  S1a) . As the PXXP motif sequence represents a core scaffold in mediating interaction with SH3 domaincontaining proteins, such as c-Abl, we sought to explore the possible link between ERa and c-Abl. To this end, lysates from HEK293 cells cotransfected with plasmids expressing Flag-c-Abl and HA-ERa were subjected to immunoprecipitation with anti-Flag, followed by immunoblotting with anti-HA. The results showed that ERa could be coimmunoprecipitated in the presence, but not in the absence, of Flag-c-Abl (Figure 1a) . The specificity of the interaction between ERa and c-Abl was also confirmed by coimmunoprecipitation analysis using normal serum (IgG). Importantly, endogenous ERa was found to be specifically coimmunoprecipitated with endogenous c-Abl (Figure 1b) . Moreover, immunofluorescence analysis of MCF-7 human breast cancer cells showed that the staining patterns of endogenous c-Abl overlapped partially with endogenous ERa, indicating their colocalization and interaction (Supplementary Figure S1b) . However, the c-Abl inhibitor STI571 reduced the staining intensity of c-Abl and ERa, resulting in weak colocalization (Supplementary Figure S1b) .
To show the interaction of ERa and c-Abl in vitro, lysates from HEK293 cells expressing Flag-ERa were incubated with glutathione S-transferase (GST)-c-Abl SH3, GST-c-Abl SH2 fusion proteins or GST. An analysis of the absorbates by immunoblotting with antiFlag showed binding of ERa to c-Abl SH3 (Figure 1c) .
To further map the c-Abl-binding sites in ERa, three mutants containing ERa, P79A, P333A or P79,333A were constructed and overexpressed together with c-Abl. Figure 1d showed that ERa interacted strongly with c-Abl, whereas much weaker interactions were observed between c-Abl and ERa, P79A and P333A, and no interaction was observed between c-Abl and ERa P79,333A, verifying that the two PXXP motifs in ERa are mainly involved in the interaction with c-Abl (Figure 1d ).
To define direct interaction between c-Abl and the two PXXP motifs, anti-Flag immunoprecipitates prepared from cells expressing Flag-ERa or Flag-ERa P79,333A were subjected to SDS-PAGE and then blotted onto a nitrocellulose membrane. After incubation with soluble GST-c-Abl-SH3 fusion protein or GST alone, the nitrocellulose membrane was incubated with an anti-GST antibody. The results showed that c-Abl SH3 only binds to wild-type (WT) ERa. As a control, Flag-ERa did not bind to GST (Supplementary Figure  S1c , middle panel). These findings indicate that the direct binding of the SH3 domain of c-Abl occurs primarily through the two PXXP motifs of ERa.
c-Abl phosphorylates ERa on the Y-52 and Y-219 sites
The association between ERa and c-Abl suggests that ERa could be a new substrate for this tyrosine kinase. This notion is supported by several lines of evidence. First, HA-ERa was coexpressed with Flag-c-Abl, and the whole-cell lysates were immunoprecipitated with anti-HA antibody. Immunoblotting of HA immunoprecipitates with a phosphotyrosine-specific antibody (anti-P-Tyr) indicated that ERa was phosphorylated by c-Abl (Figure 2a) . Second, HA-ERa was coexpressed with Flag-tagged kinase-inactive c-Abl (K290R) and analyzed for phosphorylation. Immunoblotting analysis showed that HA-ERa was phosphorylated by WT c-Abl, but not by c-Abl (K290R) (Figure 2a ). In concert with these findings, treatment with STI571 inhibited ERa phosphorylation mediated by overexpressed Flag-c-Abl in HEK293 cells (Figure 2a) . Finally, when HA-ERa was expressed to comparable levels in WT and c-Abl knockdown MCF-7 cells, the ERa protein was phosphorylated in WT cells, but to a lesser extent in c-Abl knockdown cells. Importantly, tyrosine phosphorylation of ERa was restored on Flag-c-Abl transfection into c-Abl knockdown cells (Figure 2b ). Figure  S1a) . We thus made single or combined mutation to replace the tyrosine residues in the YXXP motifs with phenylalanine. Plasmid encoding either HA-tagged WT ERa, or ERa Y52F, ERa Y219F or ERa Y52,219F mutant was confirmed by sequencing and was transfected with WT c-Abl to determine whether the in vivo c-Abl-mediated ERa phosphorylation was affected by the Y52F and Y219F mutation. Immunoblotting analysis of HA immunoprecipitates with anti-P-Tyr antibody showed reduced phosphorylation in ERa (Y52F) and the abrogation of phosphorylation in ERa (Y219F) and ERa (Y52,219F) (Figure 2c ). The HA-ERa (P79,333A) mutant that failed to interact with c-Abl also could not be phosphorylated by c-Abl (Figure 2c ). These findings indicate that c-Abl primarily phosphorylates ERa at Y219 and partially at Y52 through its interaction with ERa. To obtain evidence of direct c-Abl phosphorylation of ERa, recombinant or 
c-Abl stabilizes ERa through its phosphorylation
To examine the effect of c-Abl-mediated ERa phosphorylation on the expression levels of endogenous ERa, ERapositive human breast cancer MCF-7 cells were transfected with Flag-tagged WT c-Abl or kinase-inactive c-Abl (K290R). Figure 3a shows that the protein levels of ERa were greatly increased by WT c-Abl. In contrast, inactivation of c-Abl kinase activity by c-Abl (K290R) resulted in a complete loss of ERa upregulation. Endogenous protein levels of ERa were also greatly reduced by pretreatment of cells with the c-Abl inhibitor STI571 (Figure 3b ). These results indicate that c-Abl increases ERa protein expression in a kinase-dependent manner.
The kinase-dependent ERa upregulation suggests the possibility that the effect of c-Abl is mediated by To further delineate the mechanism underlying c-Ablmediated ERa stabilization, quantitative RT-PCR was performed. c-Abl introduction into MCF-7 cells resulted in no change in the ERa mRNA level (Figure 3d ), suggesting that c-Abl upregulates ERa by posttranscriptional modification. Indeed, the estimated half-life of the ERa protein (over 12 h) was significantly longer in the absence of ST1571 than in the presence of ST1571 (6 h) in MCF-7 cells (Figure 3e ). To examine whether functional proteasome activity involves the protein stability of ERa, MCF-7 cells were treated with STI571 with or without the proteasome inhibitor MG132. Supplementary Figure S2a shows that MG132 was able to reverse the reduced ERa protein levels by STI571, indicating that proteasome activity is involved in c-Abl-mediated ERa stabilization.
c-Abl enhances estrogen-responsive reporter transcription
Having firmly established that c-Abl is an ERa-binding protein, we tested the effect of c-Abl on the transcriptional activity of ERa. HEK293 cells, which lack ERa, were cotransfected with the ERE-LUC reporter (a synthetic estrogen-responsive reporter), as well with ERa and c-Abl. As shown in Figure 4a , c-Abl enhanced ERE-LUC activity in the presence of ERa by about 1.8-fold, whereas c-Abl alone did not show any influence on ERE-LUC activity, indicating that c-Abl regulates ERE-LUC activity in an ERa-dependent manner. To examine the effects of estrogens on ERa transactivation by c-Abl, estrogen-deprived ZR75-1 breast cancer cells were cotransfected with the ERE-LUC reporter, and with ERa and c-Abl, and subsequently treated with 17b-estradiol (E2). As shown in Figure 4b , in the absence and presence of E2, c-Abl enhanced the transcriptional activity of ERa by 2.67-and 1.75-fold, respectively, suggesting that the activation of ERa by c-Abl is ligand independent. The effect of c-Abl on the transactivation of ERa is not restricted to a single cell type, as c-Abl also enhanced the transactivation of ERa in ERapositive human breast cancer MCF-7 cells (Figure 4c ).
To determine whether c-Abl modulation of ERa transcriptional activity was kinase dependent, we tested the kinase-inactive mutant c-Abl (K290R) and STI571 for their ability to modulate ERa transcriptional activity in MCF-7 cells. Figure 4c shows that inactivation of c-Abl kinase activity by c-Abl (K290R) or STI571 almost or completely abolished c-Abl-mediated enhancement of ERa transcriptional activity, indicating that c-Abl increases ERa transactivation in a kinase-dependent manner. In concert with this, c-Abl lost its ability to enhance the transcriptional activity of ERa Y52F, ERa Y219F or ERa Y52,219F mutants (Figure 4d ), suggesting that ERa phosphorylation by c-Abl is required for the enhancement of the transactivation function of ERa.
c-Abl enhances endogenous ERa target gene transcription
As an initial step to test the effects of c-Abl on ERa target gene transcription, HEK293 cells were cotransfected with pS2-LUC (a natural estrogen-responsive reporter containing the pS2 gene promoter) or C3-LUC (a natural estrogen-responsive reporter containing the C3 gene promoter), as well as with ERa and c-Abl. As shown in Figure 5a , overexpression of c-Abl increased both pS2-LUC and C3-LUC reporter activity. To corroborate the results of the luciferase reporter assay, the effect of c-Abl on the expression of endogenous ERa target genes was examined. The E2-deprived MCF-7 cells were transfected with the empty vector or expression plasmid encoding c-Abl. Real-time RT-PCR was performed using the primers specific for ERa-responsive genes, pS2 and C3. As expected, transfection of c-Abl increased transcription of the two ERa-responsive genes (Figure 5b) . Consistent with the RT-PCR results, the increased expression of pS2 and C3 by c-Abl was also observed at the protein level by western blot (supplementary Figure S3a) . These data suggest that cAbl increases the expression of endogenous ERaresponsive genes.
To investigate the function of endogenous c-Abl in ERa target gene transcription, c-Abl siRNA or ST1571 was used. Suppression of the normal expression of c-Abl in MCF7 cells by the specific c-Abl siRNA or by the cAbl inhibitor significantly decreased the transcription activity of the two ERa-responsive genes, pS2 and C3 (Figure 5c ).
ERa Y219F mutant inhibits in vitro DNA binding and dimerization by ERa As ERa Y219 lies within the second zinc finger of the DBD (supplementary Figure S1a) , we wished to investigate the effect of its mutation on DNA binding and/or dimerization by ERa. The mutant in which tyrosine 219 was replaced by phenylalanine was used to investigate DNA binding when phosphorylation at this position is prevented. WT ERa or ERa Y219F mutant was overexpressed in HEK293 cells by transient transfection; cells were then harvested and extracts were prepared in a high-salt buffer. Gel shifts were performed by preincubation of the extracts in gel shift buffer, followed by the addition of radiolabeled ERE. A specific retarded complex was observed for WT ERa. Interestingly, a retarded complex was not shown for the ERa Y219F mutant (Figure 6a ). Immunoblotting showed that the reduced DNA binding by the ERa Y219F mutant was not because of the absence of protein or to its degradation during incubation (Figure 6a ). These results suggest that the phosphorylation of tyrosine 219 may affect DNA binding by ERa.
ERa binds DNA as a homodimer or as a heterodimer with ERb (Pace et al., 1997) . Inability of the receptor to dimerize would result in the loss of DNA binding. To investigate the effect of the ERa Y219F mutant on dimerization by ERa, we next examined the abilities of WT ERa and ERa Y219F to coimmunoprecipitate with itself. Unlike WT ERa, ERa Y219F failed to associate with ERa Y219F (Figure 6b ). These results suggest that phosphorylation of Y219 also affects dimerization by ERa. Immunofluorescence analysis of cells transfected c-Abl modulation of ERa transactivation by phosphorylation X He et al with either RFP-ERa or GFP-ERa Y219F expression plasmid showed that the ERa Y219F mutant mainly localized in the nuclear compartment, similar to WT ERa, indicating that the ERa Y219F mutant did not change its cellular localization (Figure 6c ).
Effect of c-Abl-ERa interaction on breast cancer cell growth and invasion Here, we examine the effect of c-Abl-enhanced ERamediated transactivation on breast cancer cell growth and invasion. A constitutively activated form of the ERa tyrosine Y52,219 to the glutamic acid mutant Y52,219E, which mimics c-Abl phosphorylation, was constructed. We then generated stable clones from MCF7 cells expressing either Flag-tagged ERa Y52,219E, ERa Y52,219F or Flag vectors. We characterized two individual Flag-vector control clones, two individual ERa Y52,219E clones and two individual ERa Y52,219F clones. Representative immunoblot analysis of cell lysates from exponentially growing cells revealed the expression of ERa in ERa Y52,219E and ERa Y52,219F stable clones ( Figure 7a ). As was shown in Figure 7a , both the WT ERa clone and the Flagvector control clone were able to proliferate with a doubling time of about 3 days, whereas the ERa Figure 7a ) and the ERa Y52,219E mutant exhibited rapid growth with a doubling time of about 2 days (Po0.01; Figure 7a ). To further gain an insight into the functional consequence of ER activation at residue 52 and 219, we next examined the effects of ERa phosphorylation mutant on the anchorage-independent growth ability of breast cancer cells to form colonies in soft agar, a property believed to be an in vitro variable reflective of malignancy. As shown in Figure 7b , the number of colonies formed by the ERa Y52,219F clone was reduced by about threefold compared with that of the WT ERa clone or the Flag-vector control clone (Po0.01; Figure 7b ), whereas the number of colonies formed by the ERa 52,219E clone was increased by about twofold compared with that of the WT ERa clone or the Flag-vector control clone (Po0.01; Figure 7b ). To determine whether the ERa phosphorylation mutant affected the invasiveness of breast cancer cells, matrigel invasion assays were performed. Compared with WT ERa or Flag-vector control, the ERa Y52,219F mutant dramatically inhibited invasion by about threefold (Po0.01; Figure 7c ), whereas the ERa Y52,219E mutant accelerated invasion by about twofold (Po0.01; Figure 7c ). Taken together, these results indicate that ERa phosphorylation at Y-52 and Y-219 sites by c-Abl kinase may be involved in breast cancer cell growth and invasion through modulation of ERa signaling.
Discussion
In this report, we identified ERa as a new c-Abl substrate that is phosphorylated at two tyrosine residues (Y-52 and Y-219 sites) located in the AF-1 and DBD domains of the receptor (Figures 1, 2) . Functional links between c-Abl activity and ERa activation provide 3-5) . ERa phosphorylation at the tyrosine 219 site affects DNA binding and dimerization by ERa (Figure 6) . Furthermore, the c-Abl-enhanced ERamediated transactivation is important for breast cancer cell growth and invasion (Figure 7) .
To date, a number of protein kinases for ERa phosphorylation have been identified and characterized. They include the members of the RAS/MAPK pathway, the Src family of tyrosine kinases and casein kinase II. These kinases phosphorylate ERa at multiple sites, such as Ser-104, Ser-106, Ser-118, Ser-167, Ser-236, Ser-305, Thr-311 and Tyr-537. Cyclin-A-cyclin-dependent kinase 2 (Cdk2) protein complexes phosphorylate Ser-104 and Ser-106. MAPK/ERK1/2 phosphorylates Ser-118 in a ligand-independent manner, whereas cyclin-dependent kinase (CDK) 7 phosphorylates Ser-118 in a liganddependent manner. Several kinases, such as AKT and p90 ribosomal S6 kinase, are involved in Ser-167 Figure 6 ERa Y219F mutant inhibits in vitro DNA binding and dimerization by ERa. (a) Electrophoretic mobility shift assay was performed using biotin-labeled ERE probe and nuclear proteins extracted from 293T cells transfected with Flag-tagged ERa or ERa Y219F in the presence of 10 nM E2. For competition experiments, a 100-fold molar excess of unlabeled ERE was incubated with the labeled probe. The biotin-labeled mutant ERE probe (ERE) was used as a negative control. Supershifts were performed using specific anti-ERa antibody. c-Abl modulation of ERa transactivation by phosphorylation X He et al Figure 7 Effect of c-Abl-ERa interaction on breast cancer cell growth and invasion. (a) Stably transfected clone with Flag-vector, WT ERa ERa Y52,219F or ERa Y52,219E was seeded at a density of 5 Â 10 4 cells per well in six-well plates. Cells were trypsinized at indicated times and counted with a Coulter counter. (b) Stably transfected clone with Flag-vector, WT ERa ERaY52,219F or ERa Y52,219E was resuspended in 1 ml of 0.35% agar (w/v) on top of a 1.5-ml layer of 0.5% agar (w/v) for 21 days. The dishes were photographed and colonies were counted. (c) Stably transfected clone with Flag-vector, WT ERa ERa Y52,219F or ERa Y52,219E was suspended in migration medium. Cells were allowed to invade for 48 h at 37 1C. Cells on the upper surface of the membrane were removed, and cells on the lower surface were fixed, stained and counted; n ¼ 3 independent experiments, each carried out in triplicate (points mean; bars, s.d.). The differences in cell growth, colony formation and invasion between two ERa mutant clones and the WT ERa control clone achieved statistical significance (Po0.01).
c-Abl modulation of ERa transactivation by phosphorylation X He et al phosphorylation. Protein kinase A and P21-activated kinase-1 phosphorylate ERa at Ser-236 and Ser-305, respectively. E2 activates the p38 MAPK pathway, which in turn stimulates ERa phosphorylation at Thr-311. Tyr-537 has been shown to be a major tyrosine phosphorylation site in ERa, and Src family tyrosine kinases may be responsible for phosphorylation of ERa on Tyr-537 (Arnold et al., 1994; Le Goff et al., 1994; Kato et al., 1995; Castano et al., 1997; Clark et al., 2001; Deborah, 2003; Hiroko et al., 2005; Senad et al., 2005; Acconcia et al., 2006; Rayala et al., 2006) . Our study identified two new tyrosine phosphorylation sites for cAbl, Tyr-52 and Tyr-219 (Figures 2c-d) . In general, phosphorylation of serine residues in the AF1 domain of ERa seems to influence the recruitment of coactivators, resulting in enhanced ER-mediated transcription (Deborah, 2003; Tremblay et al., 1999; Endoh et al., 1999) . Phosphorylation of tyrosine 537 leads to increased ligand-independent transcriptional activation. Our results showed that phosphorylation of ERa tyrosine 52 and tyrosine 219 by c-Abl was significantly correlated with the expression level of ERa. Similar to phosphorylation of tyrosine 537, phosphorylation of ERa tyrosine 52 and tyrosine 219 also results in enhanced ligand-independent transactivation. Most of the ERa coactivators binding to the AF-2 region of ERa have been shown to increase ERa transcriptional activity in a ligand-dependent manner. Recently, a few coactivators interact with the AF-1 or DBD region and regulate ERa transcriptional activity in a ligand-independent manner (Chakravarti et al., 1996; Yao et al., 1996; Weigel and Zhang, 1998; Alen et al., 1999; Endoh et al., 1999; Xu et al., 1999; Ding et al., 2003) . Given that c-Abl does not interact with ERa P79,333A, the ligand-independent ERa transactivation by c-Abl seems to involve the AF-1 and AF-2 domains, especially the AF1 domain.
It has been reported that c-Abl stabilizes p73 by a phosphorylation-augmented interaction (Tsai and Yuan, 2003) . Similar to this, c-Abl also stabilizes ERa through phosphorylation. The mechanism underlying the stabilization of ERa by c-Abl remains elusive. Cao et al show that c-Abl and Arg (abl-related gene) tyrosine kinases associate with and phosphorylate the proteasome PSMA7 (Liu et al., 2006) subunit at Tyr-153. Consequently, proteasome-dependent proteolysis is compromised. Whether PSMA7 phosphorylation is responsible for c-Abl-mediated ERa stabilization remains to be elucidated.
Recent studies suggest that Abl kinases are constitutively activated in breast cancer cells and constitutive activation of Abl kinases promotes breast cancer cell invasion. Although the mechanism by which BCR-Abl drives leukemiagenesis is well understood, there is little information on the effects of Abl proteins on the development or progression of solid tumors (Singer et al., 2004; Van Diest et al., 2004; Nahta et al., 2005; Nagano et al., 2006; Noren et al., 2006; Vantaggiato et al., 2006) . Here, we identify a novel mechanism by which c-Abl promotes breast cancer cell growth and invasion by upregulating ERa expression (Figure 6 ). In leukemia, Abl kinases are activated by translocation or gene amplification. In breast cancer cells, activated cAbl upregulates the ERa signaling pathway, and the ERa phosphorylation mutation that destroys c-AblERa interaction leads to decreased anchorage-dependent and -independent breast cancer cell growth and breast cancer cell invasion. Therefore, c-Abl may be a very effective target for breast cancer therapy through regulating multiple signaling pathways, such as ERa signaling.
Materials and methods

Plasmids, cell culture and transfections
The reporter constructs ERE-LUC, C3-LUC and pS2-LUC, as well as Flag-tagged ERa and HA-tagged ERa, have been described earlier (Han et al., 2006) . Flag-tagged c-Abl and its mutants have been described earlier (He et al., 2009 Plasmids encoding GST fusion proteins were generated by cloning PCR-amplified fragments into pGEX4T-2 (Amersham Biosciences Biotech, Bjo¨rkgatan, Uppsala, Sweden). GFP-cAbl and RFP-ERa were prepared by cloning PCR-amplified fragments into pDSRed and pEGFP (Biosciences Clontech, Mountain View, CA, USA). All plasmids were verified by restriction enzyme analysis and DNA sequencing.
HEK293, MCF-7 and ZR75-1 cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were treated with STI571 (Novartis, Basel, Switzerland) or MG132 (Sigma-Aldrich, St Louis, MO, USA) as described in the text. Transient and stable transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. For stable transfection, transfected cells were selected in 1200 mg/ml G418 (Invitrogen) for 3 weeks, and G418-resistant single cell clones were amplified and screened by western blot with anti-Flag antibody (Sigma-Aldrich). Two independent clones for each construct were established and used for further experiments. c-Abl downregulation was performed as described earlier (He et al., 2009) .
Immunoprecipitation and immunoblot analysis
Cell lysates were prepared in lysis buffer (50 mM Tris-HCl, pH 7.5/1 mM phenylmethylsulfonyl fluoride/1 mM dithiothreitol/ c-Abl modulation of ERa transactivation by phosphorylation X He et al 10 mM sodium fluoride/10 mg/ml aprotinin/10 mg/ml leupeptin/10 mg/ml pepstatin A containing 1% Nonidet P-40). Soluble proteins were subjected to immunoprecipitation with anti-Flag (Sigma-Aldrich), anti-c-Abl (Santa Cruz Biotech, Delaware, CA, USA) or anti-mouse IgG antibody (SigmaAldrich). An aliquot of the total lysates (5%, v/v) was included as a control. Immunoblot analysis was performed with antiMyc (Santa Cruz Biotech), anti-HA (Santa Cruz Biotech), anti-Flag (Sigma-Aldrich), anti-GFP (Santa Cruz Biotech), anti-P-Tyr (Cell Signaling, Danvers, MA, USA), anti-ERa (Sigma-Aldrich) or anti-b-tubulin (Sigma-Aldrich) antibody. The antigen-antibody complexes were visualized by chemiluminescence. When necessary, figures were cropped using Adobe Photoshop software (Adobe). Band density was analyzed using Image-Quant software (Amersham).
Immunofluorescence assay Cells were transfected as indicated and then washed briefly in PBS, fixed in 4% paraformaldehyde in PBS for 10 min. Samples were preserved in glycerol and images were captured using a Zeiss LSM510 confocal microscope.
GST pull-down assay
The GST alone and GST fusion proteins were expressed in Escherichia coli BL21 (DE3) and purified according to the manufacturer's instructions (Amersham Biosciences Biotech). Cell lysates were incubated for 2 h at 4 1C with 5 mg purified GST or GST fusion proteins bound to glutathione beads. The absorbates were washed with lysis buffer and then subjected to SDS-PAGE and immunoblot analysis. An aliquot of the total lysates (5%, v/v) was included as a loading control on the SDS-PAGE.
Luciferase reporter assays HEK293, ZR75-1 and MCF-7 cells were maintained in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS). For transfection, ZR75-1 and MCF-7 cells were seeded in 12-well plates containing phenol red-free DMEM (Invitrogen) supplemented with 5% charcoal-stripped FBS (Hyclone). The cells were transfected using Lipofectamine 2000 (Invitrogen) with 0.2 mg of ERE-LUC, pS2-LUC or C3-LUC; 50 ng of ERa expression vector; 250 ng to 1.0 mg of the expression vector for c-Abl and 0.1 mg of b-galactosidase reporter as an internal control. After treatment with 10 nM 17b-estradiol (E2) for 24 h, the transfected cells were collected and luciferase activity was assessed. All experiments were repeated at least three times in duplicate with similar results.
RNA analysis
First-strand cDNA was generated from total RNA using random priming and moloney murine leukemia virus reverse transcriptase (Invitrogen). Real-time PCR was performed using QuantiTect SYBR Green PCR Master Mix (Qiagen, Hilden, Germany) in triplicate and analyzed on an ABI Prism 7700 analyzer (Applied Biosystems, Foster, CA, USA). All real-time values were normalized to 18S ribosomal RNA. The primer sequences for pS2 are the following: 5 0 -TGACTCGGGGTCGCCTTTGGAG-3 0 (forward); 5 0 -GTGAGCCGAGGCACAGCTGCAG-3 0 (reverse). The primer sequences for C3 are the following: 5 0 -TGAGGCCATTGTGGACAAGGCAC-3 0 (forward); 5 0 -GTCACGGTCAAACACAGTGTAGTAG-3 0 (reverse). The primer sequences for ERa are the following: 5 0 -ATGACCATGACCCTCCAC-3 0 (forward); 5 0 -GTCAGACCGTGGCAGGGAA-3 0 (reverse).
Determination of the half-life of the ERa protein Cells were transfected with plasmid expressing Flag-ERa with or without ST1571. Cells were then collected by trypsinization after treatment with cycloheximide (100 mg/ml) for the indicated time points and lysed for immunoblotting analysis with anti-Flag antibody. Band density was analyzed using Image-Quant software (Amersham), with the reading normalized as a percentage of the initial ERa level (level at time ¼ 0). The percentage was then plotted against time and the half-life of the ERa protein was calculated as the time required for degradation of 50% of the protein.
In vitro kinase assays Purified GST-ERa (209-229) or GST-ERa (42-62) (2 mg) was incubated with Flag-c-Abl immunoprecipitates from transfected HEK293 cells in kinase buffer (20 mM HEPES, pH 7.5/75 mM KCl/10 mM MgCl 2 and 10 mM MnCl 2 ) containing 2.5 mCi of [g-32 P]-ATP for 30 min at 37 1C. The reaction products were analyzed by SDS-PAGE and autoradiography.
Electrophoretic mobility shift assay
The ERE (5 0 -AGCTCTTTGATCAGGTCACTGTGACCT GACTTT-3 0 ) or mutant ERE (DERE; 5 0 -AGCTCTTTGAT CAGTACACTGTGACCTGACTTT-3 0 ) probes were labeled with the Biotin 3 0 -End DNA Labeling kit (Pierce, Rockford, IL, USA) as instructed by the manufacturer. Electrophoretic mobility shift assay was performed using LightShift Chemiluminescent electrophoretic mobility shift assay kits (Pierce). Briefly, binding reactions containing 10 mg of nuclear extracts and 1 nmol of oligonucleotide were carried out for 30 min in binding buffer (2.5% glycerol, 0.05% Nonidet P-40, 50 mM KCl, 5 mM MgCl2, 1 mM EDTA, 10 mM Tris, pH 7.6 and 50 ng of poly(dI-dC)). Protein-nucleic acid complexes were resolved using a nondenaturating polyacrylamide gel consisting of 6% acrylamide, and transferred to a nylon membrane. The membrane was incubated in blocking solution, followed by incubation with streptavidin-peroxidase. After extensive washing, signal was detected with chemiluminescence solution.
Cell growth assay MCF-7 cells were seeded at a density of 5 Â 10 4 cells per well in six-well plates. Triplicate cells were then harvested on days 0, 2, 4 and 6, and counted using a Coulter counter. Cell culture medium was replenished every second day.
Assessment of colony formation in soft agar
Aliquots of 10 4 MCF-7 cells were resuspended in 1 ml of 0.35% agar (w/v) in DMEM-FBS. The aliquots were poured into sixwell dishes on top of a 1.5 ml layer of 0.5% agar (w/v) in DMEM-FBS; they were allowed to solidify and were incubated for 21 days at 37 1C in the presence of 5% CO 2 . The dishes were photographed and colony sizes were estimated, using the Image-pro Plus 4.1 software package, by determining the total area that the colonies occupied in the photographs.
Invasion assays
Cells were suspended in migration medium (basal medium containing 1% bovine serum albumin) and placed in the top well of invasion chambers (BD Biosciences, San Jose, CA, USA). Cells were allowed to invade for 48 h at 37 1C. Cells on c-Abl modulation of ERa transactivation by phosphorylation X He et al
